Gelteq Limited Ordinary Shares (GELS) - Total Liabilities

Latest as of March 2026: $5.92 Million USD

Based on the latest financial reports, Gelteq Limited Ordinary Shares (GELS) has total liabilities worth $5.92 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Gelteq Limited Ordinary Shares working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Gelteq Limited Ordinary Shares - Total Liabilities Trend (2020–2025)

This chart illustrates how Gelteq Limited Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Gelteq Limited Ordinary Shares assets under control.

Gelteq Limited Ordinary Shares Competitors by Total Liabilities

The table below lists competitors of Gelteq Limited Ordinary Shares ranked by their total liabilities.

Company Country Total Liabilities
TV Thunder Public Company Limited
BK:TVT
Thailand ฿27.59 Million
Blackrock Smaller Companies Trust PLC
LSE:BRSC
UK GBX77.48 Million
GR BUSSINES SO
F:INW
Germany €118.59K
Treasure Global Inc.
NASDAQ:TGL
USA $5.97 Million
SKAKO A/S
CO:SKAKO
Denmark Dkr8.71 Million
LCL Resources Ltd
AU:LCL
Australia AU$539.66K
Industrial Minerals Ltd
AU:IND
Australia AU$607.18K
Farlim Group (Malaysia) Bhd
KLSE:6041
Malaysia RM37.42 Million

Liability Composition Analysis (2020–2025)

This chart breaks down Gelteq Limited Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Gelteq Limited Ordinary Shares to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.09 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.42 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.29 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Gelteq Limited Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Gelteq Limited Ordinary Shares (2020–2025)

The table below shows the annual total liabilities of Gelteq Limited Ordinary Shares from 2020 to 2025.

Year Total Liabilities Change
2025-06-30 $5.67 Million +0.45%
2024-06-30 $5.65 Million +47.17%
2023-06-30 $3.84 Million +50.24%
2022-06-30 $2.55 Million +533.24%
2021-06-30 $403.23K +1.81%
2020-06-30 $396.04K --

About Gelteq Limited Ordinary Shares

NASDAQ:GELS USA Drug Manufacturers - Specialty & Generic
Market Cap
$6.21 Million
Market Cap Rank
#28329 Global
#5814 in USA
Share Price
$0.58
Change (1 day)
-5.75%
52-Week Range
$0.39 - $1.53
All Time High
$4.79
About

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Austra… Read more